Evoke Pharma says the FDA has approved its New Drug Application for Gimoti nasal spray for symptom relief in adults with acute and recurrent diabetic gastroparesis.
Evoke Pharma saw its shares jump on Wednesday after the company issued an update that it received from the FDA.
A few biotech and pharma companies were on the move Wednesday, some making absolutely massive gains on the day, giving more credence to the Trump rally and positive sentiment for the health care...
Some biotech companies made impressive runs over the course of this past week. These select few stood out from the rest.
Evoke Pharma shares saw a handy gain on Wednesday following news of a positive meeting with the FDA over Gimoti.
On Tuesday, a few biotech companies made substantial runs, either up and down, due to the results of FDA approvals, failed or passed trials and even earnings results.
July 20, 2016: Here are four stocks trading with relatively heavy volume among 13 equities making new 52-week lows in Wednesday’s session. NYSE advancers led decliners by more than 2 to 1 and...
July 18, 2016: Here are four stocks trading with relatively heavy volume among just 11 equities making new 52-week lows in Monday’s session. NYSE advancers led decliners by nearly 2 to 1 and...
Shares of Evoke Pharma rose in the market on Tuesday in the wake of solid draft guidance for its Phase 3 study.
Source: ThinkstockThe latter part of the week was difficult for the biotech and specialty pharmaceutical sector. Unsettling news out of Washington, D.C., on potential changes in the taxation of the...